A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy
- PMID: 19482892
- DOI: 10.1177/0269215509335295
A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy
Abstract
Objective: To compare the efficacy of botulinum toxin type A injection guided by different localizing techniques, electrical stimulation and palpation, to treat spasticity of the ankle plantar flexors.
Design: Randomized controlled trial.
Setting: Hospital neurology and rehabilitation department.
Participants: Sixty-five children with spastic hemiplegic or diplegic cerebral palsy.
Interventions: Botulinum toxin injection guided by electrical stimulation or palpation, and two weeks of physiotherapy.
Main outcome measures: Passive range of movement (ROM), modified Ashworth Scale, Composite Spasticity Scale, D and E dimensions of the Gross Motor Function Measure, walking velocity.
Results: Three groups improved significantly (P<50.05). The mean improvements between baseline and the end of follow-up were respectively 20, 16.2 and 11.9 degrees for passive ROM, -1.9, -1.4 and -0.7 for modified Ashworth Scale scores, -5.8, -4.2 and -2.3 for Composite Spasticity Scale scores, 18.6, 11.3 and 6.9 for Gross Motor Function Measure scores, and 0.2, 0.1 and 0.1 m/s for walking velocity in the botulinum toxin group guided by electrical stimulation injection plus physiotherapy, the botulinum toxin group guided by palpation injection plus physiotherapy, and the physiotherapy only group. The botulinum toxin injection guided by electrical stimulation group showed greater improvement in passive ROM (P<50.05), modified Ashworth Scale scores (P<50.05), Composite Spasticity Scale scores (P<50.05), and Gross Motor Function Measure scores (P<50.05) than the other two groups after treatment for three months.
Conclusions: Botulinum toxin injection guided by electrical stimulation plus physiotherapy is likely to be best in improving spasticity and functional performance in children with cerebral palsy.
Similar articles
-
Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.Clin Rehabil. 2009 Jan;23(1):64-71. doi: 10.1177/0269215508097861. Clin Rehabil. 2009. PMID: 19114438 Clinical Trial.
-
[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Wien Klin Wochenschr. 2001. PMID: 15506048 Review. German.
-
[Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):913-7. Zhonghua Er Ke Za Zhi. 2006. PMID: 17254459 Clinical Trial. Chinese.
-
[Treatment of spasticity in cerebral palsy with botulinum toxin].Rev Neurol. 2002 Jan 1-15;34(1):52-9. Rev Neurol. 2002. PMID: 11988892 Review. Spanish.
-
Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.Pediatr Rehabil. 2006 Jul-Sep;9(3):247-58. doi: 10.1080/13638490500523234. Pediatr Rehabil. 2006. PMID: 17050402 Clinical Trial.
Cited by
-
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.Cochrane Database Syst Rev. 2019 Oct 8;10(10):CD001408. doi: 10.1002/14651858.CD001408.pub2. Cochrane Database Syst Rev. 2019. PMID: 31591703 Free PMC article. Review.
-
Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?Toxins (Basel). 2020 Jul 6;12(7):440. doi: 10.3390/toxins12070440. Toxins (Basel). 2020. PMID: 32640636 Free PMC article. Review.
-
Efficacy of conservative treatment for spastic cerebral palsy children with equinus gait: a systematic review and meta-analysis.J Orthop Surg Res. 2022 Sep 8;17(1):411. doi: 10.1186/s13018-022-03301-3. J Orthop Surg Res. 2022. PMID: 36076293 Free PMC article.
-
Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey.Funct Neurol. 2013 Oct-Dec;28(4):253-8. Funct Neurol. 2013. PMID: 24598392 Free PMC article.
-
Localization modalities for botulinum neurotoxin injection.Toxicon. 2025 Sep;264:108460. doi: 10.1016/j.toxicon.2025.108460. Epub 2025 Jun 16. Toxicon. 2025. PMID: 40532883 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical